Losartan-hctz 100-12.5 MG tab 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F6SF0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,116
Award facts
- Contract value 100% obligated
- $15,115.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Losartan-HCTZ 100-12.5 mg tablets (90-count quantity) with a ceiling value of $15,115.83. This firm fixed-price delivery order, which has an ultimate completion date of January 14, 2026, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was issued on a non-set-aside basis, reflecting open competition among qualified pharmaceutical suppliers. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. The parent company, Cencora, Inc. (formerly operating as AmerisourceBergen), maintains the primary IDC relationship with DLA and has consistently demonstrated capability in fulfilling diverse pharmaceutical supply requirements on a competitive basis. Through its federal contract portfolio, the company supplies an extensive range of pharmaceutical products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DR26F6SF0?
SPE2DR26F6SF0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F6SF0 worth?
The government has obligated $15,116 on SPE2DR26F6SF0.
Is contract SPE2DR26F6SF0 an order under another contract?
Yes. SPE2DR26F6SF0 is a delivery order under SPE2DR25D2108, an indefinite delivery contract.
Was contract SPE2DR26F6SF0 competed?
The extent of competition for SPE2DR26F6SF0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award